You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. NEUROGENE INC

Neurogene Inc

XNAS: NGNE

Download real time

9.03 1.69 (23.02%)

New 52W Low in past week

541.3K XNAS Volume

XNAS 09 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
6S
11W
0O
2T
134.8

Market Cap

Below industry Median
-1.8

PE TTM

Negative PE TTM
0

PEG TTM

0.4

Price to Book

Below industry Median
0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for Neurogene Inc

The latest disclosure was made by Stuart Cobb in Neurogene Inc where a trade of 42,900 Employee Stock Option (Right to buy) done was reported to US exchanges on March 26, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Stuart Cobb Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 42,900 42,900 - - Employee Stock Option (Right to buy)
Stuart Cobb Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 7,200 27,591 - 0 Common Stock
Julie Jordan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 8,400 8,400 - 0 Common Stock
Julie Jordan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 50,300 50,300 - - Employee Stock Option (Right to buy)
Rachel McMinn Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 23,900 1,274,259 - 0 Common Stock
Rachel McMinn Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 143,500 143,500 - - Employee Stock Option (Right to buy)
Christine Mikail Cvijic President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 20,300 92,643 - 0 Common Stock
Christine Mikail Cvijic President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 122,000 122,000 - - Employee Stock Option (Right to buy)
Christine Mikail Cvijic President and CFO Sale of securities on an exchange or to another person at price $ 16.94 per share. 13 Mar 2025 4,501 72,343 - 16.9 76,247 Common Stock
Rachel McMinn Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 20.40 per share. 22 Nov 2024 47,500 1,297,859 - 20.4 969,000 Common Stock
Christine Mikail Cvijic President and CFO Purchase of securities on an exchange or from another person at price $ 20.48 per share. 22 Nov 2024 24,000 76,844 - 20.5 491,400 Common Stock
Robert Keith Woods Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 7,700 7,700 - - Stock Option (Right to Buy)
Cory Freedland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 7,700 7,700 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 7,700 7,700 - - Stock Option (Right to Buy)
Rohan Palekar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 7,700 7,700 - - Stock Option (Right to Buy)
Robert A. Baffi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 7,700 7,700 - - Stock Option (Right to Buy)
Christine Mikail Cvijic President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 31,903 52,844 - 0 Common Stock
Stuart Cobb Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 34,450 34,450 - - Stock Option (Right to Buy)
Stuart Cobb Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 20,391 20,391 - 0 Common Stock
Rachel McMinn Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 93,282 93,282 - - Employee Stock Option (Right to buy)
Christine Mikail Cvijic President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 53,900 53,900 - - Employee Stock Option (Right to buy)
Julie Jordan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 75,000 75,000 - - Stock Option (Right to Buy)
Cory Freedland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 15,400 15,400 - - Stock Option (Right to Buy)
Robert Keith Woods Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 15,400 15,400 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 15,400 15,400 - - Stock Option (Right to Buy)
Rohan Palekar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 15,400 15,400 - - Stock Option (Right to Buy)
Robert A. Baffi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 15,400 15,400 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters